Chartwell Pharmaceuticals
Alexander Zachariah is a highly experienced scientist with a strong background in method development and analytical testing within the pharmaceutical industry. Currently serving as a Senior Scientist at Chartwell Pharmaceuticals since November 2020, Alexander specializes in developing and validating HPLC and UPLC methods for drug substances and products. Previous roles include Scientist positions at Endo Pharmaceuticals and Novartis, where analytical testing and method development under cGMP and ICH guidelines were key responsibilities. Representation in project meetings and the preparation of validation reports were part of the role at Pfizer, as well as leading analytical support at Wyeth Pharmaceuticals. Alexander's career commenced as a Quality Control Chemist at Lederle Laboratories, recognized for outstanding performance, and as a Senior Chemist at Teva. Educationally, Alexander holds an MS in Chemistry from the University of Kerala.
Chartwell Pharmaceuticals
CHARTING A COURSE TO WELLNESS Chartwell Pharmaceuticals is a US-based development, manufacturing and commercial organization located in Congers, New York. Our facility produces prescription pharmaceutical products with a commitment to superior quality, compliance, and customer service. Chartwell Pharmaceuticals has a long history as a preferred manufacturing partner for prescription solid dosage products in tablet, capsule, and powders forms. Recent expansion now adds capabilities for suspensions, enemas and liquids manufacturing - including Unit Dose cups. Our rooms are large, our ceilings are high, and facilities are pristine. Our exceptional hands-on leadership team and technical staff bring decades of pharmaceutical industry experience in manufacturing and analytical services for development, scale-up, transferring, changing, launching, and supplying products. Under our own Chartwell labels, our mission is to provide a consistent, timely and quality product supply to our pharmacy customers and their patients. Our current portfolio stands at over 250 Orange Book listed ANDAs and NDAs, with an aggressive asset development and acquisition program in place. Supported by Chartwell Labs, our Formulations and Analytical team, we are quickly continuing to broaden our line through commercial Chartwell-labeled branding. Chartwell Pharmaceuticals is proud to be manufacturing "Made in the USA" products.